Last reviewed · How we verify
NCT04665102: IDLE
Pilot Study on Deep Learning in the Eye
trial testing Image classification using deep learning algorithm in Central Serous Chorioretinopathy in 120 participants. Status unknown.
1 December 2021
Quick facts
| Lead sponsor | CRG UZ Brussel |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 February 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2022 |
Drugs / interventions tested
- Image classification using deep learning algorithm
Conditions studied
- Central Serous Chorioretinopathy — all drugs for Central Serous Chorioretinopathy →
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
- Cataract — all drugs for Cataract →
Sponsor
CRG UZ Brussel — full company profile →
Who can join
Adults 18 to 100, any sex, with Central Serous Chorioretinopathy or Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Deep learning allows you to classify images using a self-learning algorithm. Transfer learning builds on an existing self-learning algorithm to enable image classification with fewer images. In this study, this technique will be applied to different image modalities in different syndromes. Retrospective study design.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04665102
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Central Serous Chorioretinopathy
Currently open trials in the same condition.
- NCT06527326 — the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy · NA · recruiting
- NCT06346405 — Central Serous Chorioretinopathy and Micropulse Laser Treatment · recruiting
- NCT05570591 — Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy · NA · recruiting
- NCT05589974 — Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy · recruiting
Other CRG UZ Brussel trials
Trials by the same sponsor.
- NCT05405686 — Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders · Phase 4 · withdrawn
- NCT05521828 — Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone · NA · unknown
- NCT05746793 — At High-risk for Pre-eclampsia After Assisted Reproductive Technology · recruiting
- NCT04997070 — Sperm Selection Using Microfluidic Technology · completed
- NCT04758871 — Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04665102 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CRG UZ Brussel
- Last refreshed: 7 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04665102.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing